Iroquois Capital Management, LLC 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-15 08:00 am Purchase | 2025-06-30 | 13G | Petros Pharmaceuticals, Inc. PTPI | Iroquois Capital Management, LLC | 3,313,704 9.990% | 3,313,704 (New Position) | Filing |